<DOC>
	<DOCNO>NCT02933021</DOCNO>
	<brief_summary>This study investigate functional consequence paraprotein production MGUS ( Monoclonal gammopathy unknown significance ) .</brief_summary>
	<brief_title>Unravel MGUS ( Monoclonal Gammopathy Unknown Significance )</brief_title>
	<detailed_description>Monoclonal gammopathy unknown significance ( MGUS ) common haematological condition . It characterise proliferation B lymphocyte clone 's associate antibody ( paraprotein ) . In case clinical symptom , however , small number individual may interaction paraprotein molecule express body ( self antigen ) . This effect normal function molecule and/or cause disease . The study aim investigate functional consequence paraprotein production MGUS .</detailed_description>
	<mesh_term>Paraproteinemias</mesh_term>
	<mesh_term>Monoclonal Gammopathy Undetermined Significance</mesh_term>
	<criteria>Participants must comply follow criterion order eligible study : Be age â‰¥18 year time inform consent form sign Have confirm document Monoclonal Gammopathy Unknown Significance ( MGUS ) diagnosis Read understand participant information sheet , sign Institutional Review Board/Independent Ethics Committee ( IRB/IEC ) approve informed consent form prior study specific evaluation Participants exclude join study match criterion : Preexisting diagnosis myeloma/lymphoma Participation therapeutic clinical study within 28 day ( 5 half life , whichever long ) enrolment study Any reason Clinical Investigator ( CI ) considers participant join study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>MGUS</keyword>
</DOC>